Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein

International Immunology

Volumn 24, Issue 4, 2012, Pages 207-218

  Tian, Jiang ^a   Zeng, Gucheng ^a   Pang, Xianwu ^a   Liang, Mifang ^b   Zhou, Junmei ^a   Fang, Danyun ^a   Liu, Yan ^a   Li, Dexin ^b   Jiang, Lifang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Dengue virus; Epitope; HLA A*0201; NS1 protein

Indexed keywords

CD27 ANTIGEN; CD45RA ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A 0201 ANTIGEN; HLA A ANTIGEN; NONSTRUCTURAL PROTEIN 1; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENGUE; DENGUE VIRUS; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROTYPE; VIRUS IMMUNITY;

EID: 84859191972     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr115     Document Type: Article

References (57)

1. Halstead, S. B. 2007. Dengue. Lancet 370:1644.
2. World Health Organization. 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New edn World Health Organization, Geneva, Switzerland.
3. World Health Organization: Media Centre. 2009. Fact Sheet No 117: Dengue and Dengue Haemorrhagic Fever. World Health Organization, Geneva, Switzerland. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/ (31 December 2011, date last accessed).
4. Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N. et al. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745.
5. Huang, K. J., Yang, Y. C., Lin, Y. S. et al. 2006. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. J. Immunol. 176:2825.
6. Yauch, L. E., Zellweger, R. M., Kotturi, M. F. et al. 2009. A protective role for dengue virus-specific CD8+ T cells. J. Immunol. 182:4865.
7. Bashyam, H. S., Green, S. and Rothman, A. L. 2006. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J. Immunol. 176:2817.
8. Beaumier, C. M., Mathew, A., Bashyam, H. S. and Rothman, A. L. 2008. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J. Infect. Dis. 197:608.
9. Wen, J. S., Jiang, L. F., Zhou, J. M., Yan, H. J. and Fang, D. Y. 2008. Computational prediction and identification of dengue virusspecific CD4(+) T-cell epitopes. Virus Res. 132:42.
10. Wen, J., Duan, Z. and Jiang, L. 2010. Identification of a dengue virus-specific HLA-A*0201-restricted CD8+ T cell epitope. J. Med. Virol. 82:642.
11. Jiang, L., Zhou, J. M., Yin, Y., Fang, D. Y., Tang, Y. X. and Jiang, L. F. 2010. Selection and identification of B-cell epitope on NS1 protein of dengue virus type 2. Virus Res. 150:49.
12. Wei, H. Y., Jiang, L. F., Fang, D. Y. and Guo, H. Y. 2003. Identification of an immuno-dominant epitope of DEN2 envelope protein and its application in diagnosis of patients. China J. Microbiol. Immunol. 23:498.
13. Chen, Y., Pan, Y., Guo, Y., Qiu, L., Ding, X. and Che, X. 2010. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1. Virology 398:290.
14. Mongkolsapaya, J., Dejnirattisai, W., Xu, X. N. et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921.
15. Libraty, D. H., Pichyangkul, S., Ajariyakhajorn, C., Endy, T. P. and Ennis, F. A. 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 75:3501.
16. Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R. and Harris, E. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J. Virol. 78:2701.
17. Rothman, A. L. and Ennis, F. A. 1999. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257:1.
18. Zivna, I., Green, S., Vaughn, D. W. et al. 2002. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J. Immunol. 168:5959.
19. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H. and Ley, T. J. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
20. Shiver, J. W., Su, L. and Henkart, P. A. 1992. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 71:315.
21. Kagi, D., Ledermann, B., Burki, K. et al. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
22. Mullbacher, A., Waring, P., Tha Hla, R. et al. 1999. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc. Natl Acad. Sci. USA 96:13950.
23. Law, R. H., Lukoyanova, N., Voskoboinik, I. et al. 2010. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447.
24. BenMohamed, L., Krishnan, R., Longmate, J. et al. 2000. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response. Hum. Immunol. 61:764.
25. Green, S., Vaughn, D. W., Kalayanarooj, S. et al. 1999. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:755.
26. Vita, R., Zarebski, L., Greenbaum, J. A. et al. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38:D854.
27. Reche, P. A., Glutting, J. P. and Reinherz, E. L. 2002. Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol. 63:701.
28. Reche, P. A., Glutting, J. P., Zhang, H. and Reinherz, E. L. 2004. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 56:405.
29. Reche, P. A. and Reinherz, E. L. 2007. Prediction of peptide-MHC binding using profiles. Methods Mol. Biol. 409:185.
30. Zhang, Y., Li, S., Shan, M. et al. 2007. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice. Immunology 121:105.
31. Ali, S. A., Lynam, J., McLean, C. S. et al. 2002. Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity. J. Immunol. 168:3512.
32. Labeur, M. S., Roters, B., Pers, B. et al. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162:168.
33. Wang, B., Chen, H., Jiang, X. et al. 2004. Identification of an HLAA* 0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 104:200.
34. Nijman, H. W., Houbiers, J. G., Vierboom, M. P. et al. 1993. Identification of peptide sequences that potentially trigger HLAA2.1-restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23:1215.
35. Micheletti, F., Monini, P., Fortini, C. et al. 2002. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 106:395.
36. Bhasin, M., Singh, H. and Raghava, G. P. 2003. MHCBN: a comprehensive database of MHC binding and non-binding peptides. Bioinformatics 19:665.
37. Zang, Y. C., Li, S., Rivera, V. M. et al. 2004. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172:5120.
38. Middleton, D., Menchaca, L., Rood, H. and Komerofsky, R. 2003. New allele frequency database. Tissue Antigens 61:403http://www.allelefrequencies.net. (31 December 2011, date last accessed).
39. Stephens, H. A., Klaythong, R., Sirikong, M. et al. 2002. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 60:309.
40. Stephens, H. A. 2010. HLA and other gene associations with dengue disease severity. Curr. Top. Microbiol. Immunol. 338:99.
41. Green, S., Pichyangkul, S., Vaughn, D. W. et al. 1999. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 180:1429.
42. Voskoboinik, I., Smyth, M. J. and Trapani, J. A. 2006. Perforinmediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6:940.
43. Makedonas, G., Banerjee, P. P., Pandey, R. et al. 2009. Rapid upregulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigenspecific CD8+ T cell cytotoxic activity. J. Immunol. 182:5560.
44. Alves, N. L., Hooibrink, B., Arosa, F. A. and van Lier, R. A. 2003. IL- induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102:2541.
45. Baars, P. A., Ribeiro Do Couto, L. M., Leusen, J. H. et al. 2000. Cytolytic mechanisms and expression of activation-regulating receptors on effector-type CD8+CD45RA+CD27- human T cells. J. Immunol. 165:1910.
46. Baars, P. A., Sierro, S., Arens, R. et al. 2005. Properties of murine (CD8+)CD27- T cells. Eur. J. Immunol. 35:3131.
47. Libraty, D. H., Young, P. R., Pickering, D. et al. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 186:1165.
48. Appay, V., Nixon, D. F., Donahoe, S. M. et al. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63.
49. Makedonas, G., Hutnick, N., Haney, D. et al. 2010. Perforin and IL-upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog. 6:e1000798.
50. Gagnon, S. J., Ennis, F. A. and Rothman, A. L. 1999. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J. Virol. 73:3623.
51. Hersperger, A. R., Makedonas, G. and Betts, M. R. 2008. Flow cytometric detection of perforin upregulation in human CD8 T cells. Cytometry A 73:1050.
52. Goodwin, R. G., Alderson, M. R., Smith, C. A. et al. 1993. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73:447.
53. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3:609.
54. Arens, R., Tesselaar, K., Baars, P. A. et al. 2001. Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 15:801.
55. Mongkolsapaya, J., Duangchinda, T., Dejnirattisai, W. et al. 2006. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J. Immunol. 176:3821.
56. Duangchinda, T., Dejnirattisai, W., Vasanawathana, S. et al. 2010. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl Acad. Sci. USA 107:16922.
57. Mathew, A. and Rothman, A. L. 2008. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol. Rev. 225:300.